Uncategorised - European Medical Journal

EMJ

Genetic Variation Affects Potency of Anti-Diabetic Drug

EFFECTIVENESS of an anti-diabetic drug depends on small, natural differences in DNA among individuals, a discovery that has paved the way…

Thrombosis in Haematological Disorders: Tailored Management Approaches

The meeting commenced with a talk from Prof Anna Falanga on the management of thrombosis in both onco-haematological and non-oncological diseases.

Why Biosimilars Matter: An Innovative Solution to Improve Patient Access

The meeting was introduced by Prof Robin Foà who spoke about the difficulties for patients Prof Foà opened the symposium by highlighting…

Perspectives on the Treatment of Mantle Cell Lymphoma and Follicular Lymphoma in 2015 and Beyond

Prof Martin Dreyling opened the symposium by providing an overview of the current status of mantle cell lymphoma (MCL) and the current guidelines…

Relapsed/Refractory Multiple Myeloma: The Current State of Play

Multiple myeloma (MM) usually responds to treatment but is incurable. The clinical course is characterised, in most patients, by a series of remissions…

IL-17 Inhibition: Emerging Perspectives in the Future Management of Axial Spondyloarthritis

The meeting was opened by Prof Atul Deodhar who introduced the prevalence, epidemiology, and clinical features of axial spondyloarthritis (axSpA), and…

IL-17 Inhibition in Spondyloarthritis: A Targeted Approach in Psoriatic Arthritis

Prof Philip Mease introduced psoriatic arthritis (PsA) with a particular emphasis on disease symptoms and an update on the status of current disease…

Pregnancy in Chronic Arthritis: Only a Matter of Planning

Chronic arthritis often affects women of childbearing age. The old concept that having chronic arthritis constitutes a major obstacle to women when…

Obesity and Osteoarthritis: More Than Just Mechanics

Osteoarthritis (OA) is the most common form of arthritis worldwide. It results in chronic pain, functional limitations, and significant social and…

Diffuse Large B Cell Lymphoma of the Foot in a Patient with Rheumatoid Arthritis

Patients with rheumatoid arthritis (RA) have an increased risk of developing malignant lymphomas, especially non-Hodgkin’s lymphoma (NHL).